Back to search

Article

Application of clinical genomic sequencing among Chinese advanced cancer patients to guide precision medicine decisions

2018-07-12

Abstract excerpt

<h4>Purpose</h4> A number of studies have suggested that high-throughput genomic analyses might improve the outcomes of cancer patients. However, whether integrative information about genomic sequencing and related clinical interpretation may benefit Chinese cancer patients with stage IV disease to date has not investigated. <h4>Methods</h4> Targeted gene panel and whole exome of tumor/blood samples in > 1,000 C...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d44c470a-c7d2-5794-8643-f44bfdf62d29
DOI
10.1101/367854
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Application of clinical genomic sequencing among Chinese advanced cancer patients to guide precision medicine decisionsDOI 10.1101/367854
The Tumor Mutational Burden of Chinese Advanced Cancer Patients Estimated by a 381-cancer-gene PanelSemantic proximity
Individualized ctDNA Fingerprints to Monitor Treatment Response and Recurrence in Multiple Cancer TypesSemantic proximity
Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types.Semantic proximity
Landscape of somatic alterations in large-scale solid tumors from an Asian populationSemantic proximity
Pragmatic Nationwide Master Observational Trial Based on Genomic Alterations in Advanced Solid Tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II Study Protocol KCSG AL-22-09Semantic proximity
Landscape of somatic alterations in large-scale solid tumors from an Asian population.Semantic proximity
Utilizing Targeted Enhanced-Whole-Genome Sequencing in Precision Oncology for the Treatment of Solid Tumors: A Clinical PerspectiveSemantic proximity
Molecular characterization of ctDNA from Chinese patients with advanced gastric adenocarcinoma reveals actionable alterations for targeted and immune therapy.Semantic proximity
Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09.Semantic proximity
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1,000 Chinese patients with cancerSemantic proximity
Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncologySemantic proximity
Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.Semantic proximity
Select a neighboring publication to make it the new centre.